These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 1351128)
1. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lifson AR; Hessol NA; Buchbinder SP; O'Malley PM; Barnhart L; Segal M; Katz MH; Holmberg SD Lancet; 1992 Jun; 339(8807):1436-40. PubMed ID: 1351128 [TBL] [Abstract][Full Text] [Related]
2. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV-infected injection drug users. Zabay JM; Sempere JM; Benito JM; Gonzalez B; Obregón E; Díez J; Fernández-Cruz E J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):266-72. PubMed ID: 7859138 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191 [TBL] [Abstract][Full Text] [Related]
4. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523 [TBL] [Abstract][Full Text] [Related]
5. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Moss AR; Bacchetti P; Osmond D; Krampf W; Chaisson RE; Stites D; Wilber J; Allain JP; Carlson J Br Med J (Clin Res Ed); 1988 Mar; 296(6624):745-50. PubMed ID: 3126959 [TBL] [Abstract][Full Text] [Related]
6. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311 [TBL] [Abstract][Full Text] [Related]
7. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection. Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441 [TBL] [Abstract][Full Text] [Related]
8. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
9. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651 [TBL] [Abstract][Full Text] [Related]
10. The predictive value of several markers in the progression to acquired immunodeficiency syndrome. Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805 [TBL] [Abstract][Full Text] [Related]
11. Immune activation markers and AIDS prognosis. Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808 [TBL] [Abstract][Full Text] [Related]
12. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection. Chironna M; Fanelli M; Potenza D; Serio G; Quarto M Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434 [TBL] [Abstract][Full Text] [Related]
13. Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment. Mulder JW; Krijnen P; Coutinho RA; Bakker M; Goudsmit J; Lange JM Genitourin Med; 1991 Jun; 67(3):188-93. PubMed ID: 1906425 [TBL] [Abstract][Full Text] [Related]
14. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Mellors JW; Kingsley LA; Rinaldo CR; Todd JA; Hoo BS; Kokka RP; Gupta P Ann Intern Med; 1995 Apr; 122(8):573-9. PubMed ID: 7887550 [TBL] [Abstract][Full Text] [Related]
15. Beta-2 microglobulin as a predictor of prognosis in HIV-infected men with haemophilia: a proposed strategy for use in clinical care. Sabin CA; Phillips AN; Lee CA; Elford J; Timms A; Bofill M; Janossy G Br J Haematol; 1994 Feb; 86(2):366-71. PubMed ID: 7911035 [TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448 [TBL] [Abstract][Full Text] [Related]
17. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341 [TBL] [Abstract][Full Text] [Related]
18. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. Jacobson MA; Abrams DI; Volberding PA; Bacchetti P; Wilber J; Chaisson RE; Crowe S; Howard W; Moss A J Infect Dis; 1989 Jun; 159(6):1029-36. PubMed ID: 2566637 [TBL] [Abstract][Full Text] [Related]
19. Immunological markers of disease progression in patients infected with the human immunodeficiency virus. Pascale JM; Isaacs MD; Contreras P; Gomez B; Lozano L; Austin E; De Martin MC; Gregory RL; McLaughlin GL; Amador A Clin Diagn Lab Immunol; 1997 Jul; 4(4):474-7. PubMed ID: 9220167 [TBL] [Abstract][Full Text] [Related]
20. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS]. Halota W; Jaruga B; Pawłowska M Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]